Christian Voigtlander - 25 Nov 2024 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
Chief Operating Officer
Signature
By: Paula Darbyshire, Attorney-in-fact For: Christian Voigtlander
Issuer symbol
ICUI
Transactions as of
25 Nov 2024
Transactions value $
-$622,506
Form type
4
Filing time
26 Nov 2024, 18:20:33 UTC
Previous filing
30 May 2024
Next filing
27 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $190K +1.96K $96.83 1.96K 25 Nov 2024 Direct
transaction ICUI Common Stock Sale -$332K -1.96K -100% $169.08 0 25 Nov 2024 Direct F1
transaction ICUI Common Stock Options Exercise $747K +7.72K $96.83 7.72K 26 Nov 2024 Direct
transaction ICUI Common Stock Sale -$1.2M -7.51K -97.33% $159.09 206 26 Nov 2024 Direct F2
transaction ICUI Common Stock Sale -$33K -206 -100% $160.09 0 26 Nov 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -1.96K -2.94% $0.00 64.7K 25 Nov 2024 Common Stock 1.96K $96.83 Direct
transaction ICUI Non-Qualified Stock Option (right to buy) Options Exercise $0 -7.72K -11.93% $0.00 57K 26 Nov 2024 Common Stock 7.72K $96.83 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $169.00 to $169.45, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F2 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $159.00 to $159.86, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.
F3 The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $160.09 to $160.24, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4.